Salicylic Acid

Primary uses

• Keratolytic and exfoliating action in topical formats
• Oil-soluble access into sebaceous pores
• Preservation-adjacent activity in some systems
• Anti-dandruff positioning in scalp formats

Applications

• Facial cleansers, toners and treatments
• Acne and blemish formats
• Scalp and anti-dandruff products
• Foot and callus care

Advantages

• Well-established performance in blemish and scalp formats with strong consumer familiarity
• Works in both leave-on and rinse-off systems when the solvency problem is solved
• Recognised by formulators and regulators, so the development path is well trodden

Limitations to consider

• Poor water solubility requires a solvent system, which shapes the whole formulation
• Effectiveness is pH dependent, so the finished pH must be controlled tightly
• Regulatory framework for the finished product may be a drug or OTC pathway and is the brand owner's responsibility
• Use level is established in your own formulation by bench trial and stability testing. Supplier literature ranges are a starting point for that work, not a specification, and they are not reproduced here as one.
• Colour, odour and sensory behaviour vary between manufacturing sources even where the INCI name is identical, and in personal care those differences are visible to the end consumer. Approve a production-representative sample against your own finished format before the first commercial shipment.

How to choose the right grade

• Define the claim the finished brand intends to make, and confirm who is responsible for substantiating it
• Confirm the pH window and the stability constraints the active imposes on the whole formula
• Establish the addition phase and temperature, since many actives degrade in a hot phase
• Plan finished-product stability testing including colour and odour over the intended shelf life
• Confirm the documentation your quality system requires before the material enters a batch record
• Design the solvent system before selecting the level, since solubility is the limiting factor
• Confirm which regulatory pathway the finished product will follow in Canada before development starts
• Bench results do not transfer automatically to production. Order of addition, shear, neutralisation and cooling profile all change behaviour at scale, so plan a pilot batch on the intended equipment before committing to a production volume.
• Exact specification is confirmed against supplier documentation at quotation.

Typical grades

• Powder grades traded against declared assay and pharmacopoeial vocabulary
• Grades differentiated by declared particle size
• Buyers search for personal-care, cosmetic and pharmaceutical grade material by name, and those words describe what the buyer needs rather than what is asserted here. Which grade a specific offer corresponds to, and what documentation supports it, is read from the supplier documentation for the exact product quoted.
• Active matter, assay and purity are per-offer values that are declared by the supplier for the exact lot. They change both the use level in the formulation and the true cost per unit of function delivered, so quotations are compared on declared active content rather than on price per kilogram.
• Natural, plant-derived, hypoallergenic, dermatologically tested and similar positioning statements belong to the finished brand and must be supported by the brand owner's own evidence. Any such wording attached to a raw material is treated here as a buyer search term, not as a substantiated property of the material offered.